About EyePoint Pharmaceuticals
EyePoint Pharmaceuticals is a company based in Watertown (United States) founded in 1987 was acquired by pSivida in March 2018.. The company has 165 employees as of December 31, 2024. EyePoint Pharmaceuticals has completed 2 acquisitions, including Contractordeliverysystems and Icon Bioscience. EyePoint Pharmaceuticals offers products and services including DURAVYU™ and Durasert E™. EyePoint Pharmaceuticals operates in a competitive market with competitors including Rezolute, Molecular Partners, Aviceda Therapeutics, IVERIC bio and EyeBio, among others.
- Headquarter Watertown, United States
- Employees 165 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eyepoint Pharmaceuticals, Inc.
-
Annual Revenue
$43.27 M-5.97as on Dec 31, 2024
-
Net Profit
$-130.87 M-84.86as on Dec 31, 2024
-
EBITDA
$-144.31 M-97.16as on Dec 31, 2024
-
Latest Funding Round
$15.7 M (USD), Post-IPO
Jan 03, 2021
-
Investors
pSivida
& 5 more
-
Employee Count
165
as on Dec 31, 2024
-
Investments & Acquisitions
Contractordeliverysystems
& 1 more
-
Acquired by
pSivida
(Mar 28, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of EyePoint Pharmaceuticals
EyePoint Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol EYPT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of EyePoint Pharmaceuticals
EyePoint Pharmaceuticals offers a comprehensive portfolio of products and services, including DURAVYU™ and Durasert E™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational treatment for VEGF mediated retinal diseases.
Proprietary system for sustained intraocular drug delivery.
Funding Insights of EyePoint Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $15.7M
-
First Round
First Round
(28 Mar 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Post-IPO - EyePoint Pharmaceuticals | Valuation |
investors |
|
| Feb, 2019 | Amount | Debt – Conventional - EyePoint Pharmaceuticals | Valuation |
investors |
|
| Oct, 2018 | Amount | Post-IPO - EyePoint Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EyePoint Pharmaceuticals
EyePoint Pharmaceuticals has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include pSivida, OcuMension and SWK Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Founded Year | Domain | Location | |
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
Ophthalmic drugs for eye disorders are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EyePoint Pharmaceuticals
EyePoint Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Contractordeliverysystems and Icon Bioscience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online pharmacy providing prescription drugs and other health products
|
2004 | ||||
|
Provider of commercial construction services including concrete, painting, and tenant finish
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - EyePoint Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eyepoint Pharmaceuticals Comparisons
Competitors of EyePoint Pharmaceuticals
EyePoint Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rezolute, Molecular Partners, Aviceda Therapeutics, IVERIC bio and EyeBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Gene therapy solutions for retinal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for ophthalmological diseases are developed to restore vision.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eyepoint Pharmaceuticals
Frequently Asked Questions about EyePoint Pharmaceuticals
When was EyePoint Pharmaceuticals founded?
EyePoint Pharmaceuticals was founded in 1987 and raised its 1st funding round 31 years after it was founded.
Where is EyePoint Pharmaceuticals located?
EyePoint Pharmaceuticals is headquartered in Watertown, United States.
How many employees does EyePoint Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at EyePoint Pharmaceuticals is 165.
What is the annual revenue of EyePoint Pharmaceuticals?
Annual revenue of EyePoint Pharmaceuticals is $43.27M as on Dec 31, 2024.
What does EyePoint Pharmaceuticals do?
EyePoint Pharmaceuticals was founded in 1987 and is headquartered in Watertown, United States. Operations focus on the biotechnology sector, where small molecule-based therapeutics for ophthalmic disorders are developed. A proprietary Durasert technology is employed, consisting of a miniaturized, injectable, sustained-release drug delivery system for small molecules. Lead candidates include Yutiq, targeted at chronic non-infectious uveitis, and EYEP-1901, addressed to wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.
Who are the top competitors of EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals's top competitors include Rezolute, Molecular Partners and Aviceda Therapeutics.
What products or services does EyePoint Pharmaceuticals offer?
EyePoint Pharmaceuticals offers DURAVYU™ and Durasert E™.
Is EyePoint Pharmaceuticals publicly traded?
Yes, EyePoint Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol EYPT.
How many acquisitions has EyePoint Pharmaceuticals made?
EyePoint Pharmaceuticals has made 2 acquisitions, including Contractordeliverysystems, and Icon Bioscience.
Who are EyePoint Pharmaceuticals's investors?
EyePoint Pharmaceuticals has 6 investors. Key investors include pSivida, OcuMension, SWK Holdings, CRG, and EW Healthcare Partners.
What is EyePoint Pharmaceuticals's ticker symbol?
The ticker symbol of EyePoint Pharmaceuticals is EYPT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.